Europe · Regional markets · El Economista

España está un paso más cerca de una nueva vacuna contra la tuberculosis tras dos avances clínicos decisivos: podría llegar al mercado antes de 2030

Published by El Economista · Spain 9 h ago

La vacuna española contra la tuberculosis MTBVAC ha completado la vacunación de 7.120 recién nacidos en un ensayo clínico de fase 3 y de 5.500 adolescentes y adultos en un estudio…

Read the full article on El Economista Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.eleconomista.es)

Also worth reading

This is Money

What you were asking Steve Webb about pensions a decade ago… and what is worrying savers now

City A.M.

Wealthy investors accelerate gifting amid fears of Budget tax raid

Finews

«150 Reactors in Five Years: There Isn’t Enough Electricity to Fulfill the AI Investment Delusion»

MoneyWeek

Is technical analysis dead? How finance fell out of love with chartism

Investors Chronicle

UK inflation set to jump: Economic week ahead – 19-23 Oct

WirtschaftsWoche